Chandrasekhar Sinha

Title: Innovations of Chandrasekhar Sinha

Introduction

Chandrasekhar Sinha is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work has led to the development of a patented process that enhances the efficiency of drug synthesis.

Latest Patents

Chandrasekhar Sinha holds a patent for the "Process for the preparation of intermediates useful in the synthesis of Eluxadoline." This invention relates to an improved process for preparing [(S)-1-(4-phenyl-1-H-imidazol-2-yl)-ethyl]-amine. The process involves the formation of a novel intermediate crystalline compound, specifically [(S)-1-(4-phenyl-1-H-imidazol-2-yl)-ethyl]-carbamic acid tert-butyl ester oxalate. This innovation is crucial for the pharmaceutical industry, as it streamlines the synthesis of a compound used in treating gastrointestinal disorders.

Career Highlights

Chandrasekhar Sinha is associated with Allergan Holdings Unlimited Company, where he applies his expertise in drug development. His work has been instrumental in advancing the company's research initiatives and enhancing its product offerings. With a focus on innovative solutions, he continues to contribute to the field of pharmaceuticals.

Collaborations

Chandrasekhar has collaborated with notable colleagues, including Parven Kumar Luthra and Syed Aziz Imam Quadri. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their projects.

Conclusion

Chandrasekhar Sinha's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical implications for drug development.